These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12040443)

  • 21. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
    Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
    Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of the RT-PCR assay of PML-RARA transcripts in acute promyelocytic leukemia. The Leukemia Study Group of the Ministry of Health and Welfare (Kouseisho).
    Fukutani H; Naoe T; Ohno R; Yoshida H; Kiyoi H; Miyawaki S; Morishita H; Sano F; Kamibayashi H; Matsue K
    Leukemia; 1995 Apr; 9(4):588-93. PubMed ID: 7723389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
    Kwong YL; Au WY; Chim CS; Pang A; Suen C; Liang R
    Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on conversion of RARalpha/PML fusion gene in acute promyelocytic leukemia].
    Liu Y; Le X; Xue W; Yu X; Guo N; Lu D; Chen S
    Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):400-2. PubMed ID: 15625843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
    Breccia M; Diverio D; Noguera NI; Visani G; Santoro A; Locatelli F; Damiani D; Marmont F; Vignetti M; Petti MC; Lo Coco F
    Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute promyelocytic leukemia accompanied by scrotal Fournier's gangrene during ATRA treatment and relapsed as external ear tumor].
    Goto H; Tsurumi H; Kasahara S; Hara T; Yamada T; Sawada M; Tanabashi S; Kametani M; Moriwaki H
    Rinsho Ketsueki; 1998 Dec; 39(12):1169-74. PubMed ID: 10028849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunofluorescent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia.
    Gomis F; Sanz J; Sempere A; Plumé G; Senent ML; Pérez ML; Cervera J; Moscardó F; Bolufer P; Barragán E; Martín G; Sanz MA
    Ann Hematol; 2004 Nov; 83(11):687-90. PubMed ID: 15278297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure.
    Gallagher RE; Schachter-Tokarz EL; Zhou DC; Ding W; Kim SH; Sankoorikal BJ; Bi W; Livak KJ; Slack JL; Willman CL
    Leukemia; 2006 Apr; 20(4):556-62. PubMed ID: 16437139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia.
    Castagnola C; Elena C; Merli M
    Haematologica; 2008 Feb; 93(2):e28. PubMed ID: 18245644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of RT-PCR PML-RARA transcript monitoring for extramedullary relapse of acute promyelocytic leukemia in the pleura, heart and pericardium after allogeneic SCT.
    Nasilowska-Adamska B; Majewski M; Seferynska I; Szczepinski A; Tomaszewska A; Prochorec-Sobieszek M; Guz K; Torbicki A; Warzocha K; Marianska B
    Ann Transplant; 2007; 12(3):33-8. PubMed ID: 18290568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint.
    Biondi A; Luciano A; Bassan R; Mininni D; Specchia G; Lanzi E; Castagna S; Cantù-Rajnoldi A; Liso V; Masera G
    Leukemia; 1995 Sep; 9(9):1461-6. PubMed ID: 7658712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment concepts of acute promyelocytic leukemia.
    Lengfelder E; Saussele S; Weisser A; Büchner T; Hehlmann R
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [PML (promyelocytic leukemia). Oncogene].
    Soussi T; de Thé H
    Bull Cancer; 1999 Feb; 86(2):133. PubMed ID: 10094521
    [No Abstract]   [Full Text] [Related]  

  • 36. Central nervous system involvement at the time of presentation in acute promyelocytic leukemia.
    Collins C; Knoderer H
    Pediatr Blood Cancer; 2010 Apr; 54(4):603-5. PubMed ID: 19998465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia.
    Diverio D; Riccioni R; Mandelli F; Lo Coco F
    Haematologica; 1995; 80(2):155-60. PubMed ID: 7628753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia.
    Albano F; Zagaria A; Anelli L; Coccaro N; Tota G; Brunetti C; Minervini CF; Impera L; Minervini A; Cellamare A; Orsini P; Cumbo C; Casieri P; Specchia G
    Oncotarget; 2015 May; 6(15):13269-77. PubMed ID: 25944686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late relapses in acute promyelocytic leukaemia.
    Latagliata R; Carmosino I; Breccia M; Minni A; Testi A; Iorio N; Lo-Coco F; Avvisati G; Petti MC; Mandelli F; Cimino G
    Acta Haematol; 2007; 117(2):106-8. PubMed ID: 17135723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
    Lou Y; Ma Y; Sun J; Ye X; Pan H; Wang Y; Qian W; Meng H; Mai W; He J; Tong H; Jin J
    Ann Hematol; 2015 Nov; 94(11):1829-37. PubMed ID: 26294332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.